Drugs / 2 TU Tuberculin PPD RT 23 SSI
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01242475 Comparator | Apr → Nov 2011 | tuberculosis | Statens Serum Institut | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2 TU Tuberculin PPD RT 23 SSI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01242475 ↗ |
| Route | Other | “given intradermally by the Mantoux technique” NCT01242475 ↗ |